World Patient Safety Day, is an initiative by the World Health Organisation to raise awareness of the need to continuously improve patient safety, building on the foundations of a safer culture and safer systems.
World Patient Safety Day 2020 will bring together health workers, patients, families, caregivers, communities, health care leaders and policy-makers, all showing commitment to health worker safety and patient safety. Health workers include all people engaged in actions whose primary intent is to enhance health. The year 2020 has been designated as the International Year of the Nurse and Midwife
‘Safe health workers, Safe patients’
Members of the C Diff Foundation recognize the importance of this annual WHO “World Patient Safety Day” campaign and we ask fellow patients, health workers, health care leaders, patients, and healthcare professionals to actively participate and share this information with others.
Share using any of the following hashtags: #PatientSafety#WorldPatientSafetyDay#HealthWorker
Thursday, September 17th is World Patient Safety Day. No one should be harmed in health care. And yet, every day, thousands of patients suffer avoidable harm while receiving care. The ongoing COVID-19 pandemic has exerted unprecedented pressure on health systems and health workers. An alarming number of health workers have also been harmed while responding to the COVID-19 pandemic. Safety of health workers has a significant impact on the safety of patients In view of this, the theme of World Patient Safety Day this year is Health Worker Safety: A Priority for Patient Safety. If you or a loved one are a patient, be actively involved in your own care. Enhance your knowledge about safety in health care and raise safety concerns with your health providers. Ask questions to be aware of your health condition and treatment. Speak up for the safety of your care as well as the safety of health workers!
“Clean care for all – it’s in your hands” — this year’s slogan
SAVE LIVES: Clean YOUR Hands global annual campaign kicks off on May 5th.
As the World Health Organization shared in their newsletter; “Being “campaign active” is an important part of improving hand hygiene and Infection Prevention and Control (IPC) in health care.”
“Health facilities should always be places of healing. No one should get sick while seeking care. Achieving universal health coverage means quality care for everyone, everywhere. And quality care is clean care. We all have a part to play; hand hygiene is one of the most basic elements of infection prevention and control.” Dr Tedros Adhanom Ghebreyesus, WHO Director-General, advocacy video (https://youtu.be/nw9TMfqc3cE).
Visit the WHO website to gain access to the resources available and being “campaign active” to share the high levels of the importance of this life-saving intervention across the globe.
Global Antibiotic Research and Development Partnership (GARDP) – GARDP is a non-profit research and development organization initiated by WHO and the Drugs for Neglected Disease initiative, that addresses global public health needs by developing and delivering new or improved antibiotic treatments, while endeavouring to ensure their sustainable access. GARDP recently launched the COHERENCE (COmbination tHERapy to treat sepsis due to carbapenem-resistant Gram negative bacteria in adult and paediatric population: EvideNCE and common practice) project. As a first activity, COHERENCE launched a survey assessing the prescription habits and attitudes of clinicians who normally deal with the treatment of carbapenem-resistant Gram negative bacteria in adult and paediatric populations worldwide. Please promote the survey and participate here (https://www.surveymonkey.com/r/GARDP-COHERENCE)! By completing the survey, you will have a chance to win a complimentary registration for the 2020 ECCMID Congress in Paris.
the WHO has ranked world’s most deadly “Superbugs” in the world:
Three bacteria were listed as critical:
Acinetobacter baumannii bacteria that are resistant to important antibiotics called carbapenems. These are highly drug resistant bacteria that can cause a range of infections for hospitalized patients, including pneumonia, wound, or blood infections.
Pseudomonas aeruginosa, which are resistant to carbapenems. These bacteria can cause skin rashes and ear infectious in healthy people but also severe blood infections and pneumonia when contracted by sick people in the hospital.
Enterobacteriaceae that are resistant to both carbepenems and another class of antibiotics, cephalosporins. This family of bacteria live in the human gut and includes bugs such as E. coli and Salmonella.
The list, which was released February 27th, 2017 and enumerates 12 bacterial threats, grouping them into three categories: critical, high, and medium.
“Antibiotic resistance is growing and we are running out of treatment options. If we leave it to market forces alone, the new antibiotics we most urgently need are not going to be developed in time,” said Dr. Marie-Paule Kieny, the WHO’s assistant director-general for health systems and innovation.
The international team of experts who drew up the new list urged researchers and pharmaceutical companies to focus their efforts on a type of bacteria known as Gram negatives.
(The terminology relates to how the bacteria respond to a stain — developed by Hans Christian Gram — used to make them easier to see under a microscope.)
Dr. Nicola Magrini, a scientist with the WHO’s department of innovation, access and use of essential medicines, said pharmaceutical companies have recently spent more efforts trying to find antibiotics for Gram positive bacteria, perhaps because they are easier and less costly to develop.
Gram negative bacteria typically live in the human gut, which means when they cause illness it can be serious bloodstream infections or urinary tract infections.
Gram positive bacteria are generally found outside the body, on the skin or in the nostrils.
Kieny said the 12 bacteria featured on the priority list were chosen based on the level of drug resistance that already exists for each, the numbers of deaths they cause, the frequency with which people become infected with them outside of hospitals, and the burden these infections place on health care systems.
Paradoxically, though, she and colleagues from the WHO could not provide an estimate of the annual number of deaths attributable to antibiotic-resistant infections. The international disease code system does not currently include a code for antibiotic-resistant infections; it is being amended to include one.
Six (6) others were listed as high priority for new antibiotics. That grouping represents bacteria that cause a large number of infections in otherwise healthy people. Included there is the bacteria that causes gonorrhea, for which there are almost no remaining effective treatments.
Three (3) other bacteria were listed as being of medium priority, because they are becoming increasingly resistant to available drugs. This group includes Streptococcus pneumoniae that is not susceptible to penicillin. This bacterium causes pneumonia, ear and sinus infections, as well as meningitis and blood infections.
The creation of the list was applauded by others working to combat the rise of antibiotic resistance.
“This priority pathogens list, developed with input from across our community, is important to steer research in the race against drug resistant infection — one of the greatest threats to modern health,” said Tim Jinks, head of drug-resistant infections for the British medical charity Wellcome Trust.
“Within a generation, without new antibiotics, deaths from drug-resistant infection could reach 10 million a year. Without new medicines to treat deadly infection, lifesaving treatments like chemotherapy and organ transplant, and routine operations like caesareans and hip replacements, will be potentially fatal.”
The first World Antibiotic Awareness Week will be held from 16 to 22 November 2015. The campaign aims to increase awareness of global antibiotic resistance and to encourage best practices among the general public, health workers and policy makers to avoid the further emergence and spread of antibiotic resistance.